These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 27884518)
1. Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening. Johnson DH; Kisiel JB; Burger KN; Mahoney DW; Devens ME; Ahlquist DA; Sweetser S Gastrointest Endosc; 2017 Mar; 85(3):657-665.e1. PubMed ID: 27884518 [TBL] [Abstract][Full Text] [Related]
2. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population. Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091 [TBL] [Abstract][Full Text] [Related]
3. Performance of multitarget stool DNA testing in African American patients. Cooper GS; Markowitz SD; Chen Z; Tuck M; Willis JE; Berger BM; Brenner DE; Li L Cancer; 2018 Oct; 124(19):3876-3880. PubMed ID: 30193399 [TBL] [Abstract][Full Text] [Related]
4. The Utility of Multitarget Stool DNA Testing for Colorectal Cancer Screening After a Normal Colonoscopy. Rao AK; Kalra S; Van Leer-Greenberg B; Rockey DC J Gastrointest Cancer; 2024 Oct; 56(1):2. PubMed ID: 39414672 [TBL] [Abstract][Full Text] [Related]
5. Influence of Colorectal Cancer Risk Factors on Predictive Value of a Positive Multitarget Stool DNA Test. Narayani KR; Narayani RI J Clin Gastroenterol; 2024 May-Jun 01; 58(5):471-474. PubMed ID: 37389965 [TBL] [Abstract][Full Text] [Related]
6. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients. Prince M; Lester L; Chiniwala R; Berger B World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082 [TBL] [Abstract][Full Text] [Related]
7. Colonoscopy Findings in FIT+ and mt-sDNA+ Patients versus in Colonoscopy-only Patients: New Hampshire Colonoscopy Registry Data. Anderson JC; Robinson CM; Hisey W; Limburg PJ; Butterly LF Cancer Prev Res (Phila); 2022 Jul; 15(7):455-464. PubMed ID: 35378546 [TBL] [Abstract][Full Text] [Related]
9. Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy. Eckmann JD; Ebner DW; Bering J; Kahn A; Rodriguez E; Devens ME; Lowrie KL; Doering K; Then S; Burger KN; Mahoney DW; Prichard DO; Wallace MB; Gurudu SR; Finney LJ; Limburg P; Berger B; Ahlquist DA; Kisiel JB Am J Gastroenterol; 2020 Apr; 115(4):608-615. PubMed ID: 32068535 [TBL] [Abstract][Full Text] [Related]
10. Detection of High-Risk Sessile Serrated Lesions: Multitarget Stool DNA Versus CT Colonography. Deiss-Yehiely N; Graffy PM; Weigman B; Hassan C; Matkowskyj KA; Pickhardt PJ; Weiss JM AJR Am J Roentgenol; 2022 Apr; 218(4):670-676. PubMed ID: 34755523 [No Abstract] [Full Text] [Related]
11. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes. Fendrick AM; Fisher DA; Saoud L; Ozbay AB; Karlitz JJ; Limburg PJ Cancer Prev Res (Phila); 2021 Sep; 14(9):845-850. PubMed ID: 34021023 [TBL] [Abstract][Full Text] [Related]
13. PPV and Detection Rate of mt-sDNA Testing, FIT, and CT Colonography for Advanced Neoplasia: A Hierarchic Bayesian Meta-Analysis of the Noninvasive Colorectal Screening Tests. Pickhardt PJ; Correale L; Hassan C AJR Am J Roentgenol; 2021 Oct; 217(4):817-830. PubMed ID: 33703913 [No Abstract] [Full Text] [Related]
14. Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing. Cooper GS; Markowitz SD; Chen Z; Tuck M; Willis JE; Berger BM; Brenner DE; Li L Dig Dis Sci; 2018 Jun; 63(6):1449-1453. PubMed ID: 29516325 [TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia. Ladabaum U; Mannalithara A Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Performance of Multitarget Stool DNA and CT Colonography for Noninvasive Colorectal Cancer Screening. Pickhardt PJ; Graffy PM; Weigman B; Deiss-Yehiely N; Hassan C; Weiss JM Radiology; 2020 Oct; 297(1):120-129. PubMed ID: 32779997 [TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People. Redwood DG; Dinh TA; Kisiel JB; Borah BJ; Moriarty JP; Provost EM; Sacco FD; Tiesinga JJ; Ahlquist DA Mayo Clin Proc; 2021 May; 96(5):1203-1217. PubMed ID: 33840520 [TBL] [Abstract][Full Text] [Related]
18. Serrated Polyp Yield at Colonoscopy in Patients with Positive FIT, Positive mt-sDNA, and Colonoscopy Only: Data from the New Hampshire Colonoscopy Registry. Anderson JC; Hisey WM; Robinson CM; Limburg PJ; Kneedler BL; Butterly LF Cancer Epidemiol Biomarkers Prev; 2023 Feb; 32(2):226-232. PubMed ID: 36409472 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults. Sharma T Public Health; 2020 May; 182():70-76. PubMed ID: 32179290 [TBL] [Abstract][Full Text] [Related]
20. Fecal DNA Testing for Colorectal Cancer Screening. Carethers JM Annu Rev Med; 2020 Jan; 71():59-69. PubMed ID: 31451044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]